A detailed history of Addison Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Addison Advisors LLC holds 25 shares of MRNA stock, worth $984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 50 50.0%
Holding current value
$984
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$63.64 - $125.14 $1,591 - $3,128
-25 Reduced 50.0%
25 $1,000
Q2 2023

Aug 03, 2023

SELL
$118.5 - $160.53 $8,176 - $11,076
-69 Reduced 57.98%
50 $6,000
Q1 2023

May 09, 2023

SELL
$135.66 - $197.02 $406 - $591
-3 Reduced 2.46%
119 $18,000
Q4 2022

Feb 07, 2023

SELL
$118.38 - $210.04 $355 - $630
-3 Reduced 2.4%
122 $21,000
Q2 2022

Aug 04, 2022

BUY
$117.13 - $176.59 $702 - $1,059
6 Added 5.04%
125 $18,000
Q1 2022

Apr 29, 2022

SELL
$126.46 - $235.05 $6,196 - $11,517
-49 Reduced 29.17%
119 $20,000
Q4 2021

Jan 31, 2022

BUY
$225.82 - $368.51 $37,937 - $61,909
168 New
168 $43,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.